Patents by Inventor Faina Karasina

Faina Karasina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE DEXAMETHASONE FORMULATION
    Publication number: 20230078906
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 16, 2023
    Inventors: Vernon G. WONG, William S. WHITE, Mae W. HU, Glenn T. HUANG, Faina KARASINA
  • SUSTAINED RELEASE DEXAMETHASONE FORMULATION
    Publication number: 20190105330
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery
    Type: Application
    Filed: December 10, 2018
    Publication date: April 11, 2019
    Inventors: Vernon G. WONG, William S. WHITE, Mae W. HU, Glenn T. HUANG, Faina KARASINA
  • Use of sustained release dexamethasone in post-cataract surgery inflammation
    Patent number: 10159683
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: December 25, 2018
    Assignee: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. Wong, William S. White, Mae W. Hu, Glenn T. Huang, Faina Karasina
  • USE OF SUSTAINED RELEASE DEXAMETHASONE IN POST-CATARACT SURGERY INFLAMMATION
    Publication number: 20180303851
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery
    Type: Application
    Filed: June 26, 2018
    Publication date: October 25, 2018
    Inventors: Vernon G. WONG, William S. WHITE, Mae W. HU, Glenn T. HUANG, Faina KARASINA
  • Use of sustained release dexamethasone in post-cataract surgery inflammation
    Patent number: 10028965
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: July 24, 2018
    Assignee: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. Wong, William S. White, Mae W. Hu, Glenn T. Huang, Faina Karasina
  • USE OF SUSTAINED RELEASE DEXAMETHASONE IN POST-CATARACT SURGERY INFLAMMATION
    Publication number: 20160120879
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery
    Type: Application
    Filed: May 23, 2014
    Publication date: May 5, 2016
    Inventors: Vernon G. Wong, William S. White, Mae W. Hu, Glenn T. Huang, Faina Karasina